ASP9853, an Inhibitor of Inducible Nitric Oxide Synthase Dimerization, in Combination With Docetaxel: Preclinical Investigation and a Phase I Study in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-016-2967-0
Full Text
Open PDFAbstract
Available in full text
Date
January 25, 2016
Authors
Publisher
Springer Science and Business Media LLC